Intellectual Property India Publishes Patent Application for Salts And Polymorphic Forms Of Revumenib

MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617067574 A) filed by Syndax Pharmaceuticals, Inc. on May 29, 2026, for Salts And Polymorphic Forms Of Revumenib.

Inventors include Marolewski, Ariane; Kattuboina, Venkata A.; and Fulzele, Suniket.

The application for the patent was published on June 19, 2026, under issue no. 25/2026.

Abstract: The present disclosure relates to a novel salt and salt forms of Compound (A). The disclosure is also directed to pharmaceutical compositions containing Compound (A) citrate salt or salt forms and to the therapeutic use of such salts, salt forms, and compositions thereof.

Disclaimer: Curated by HT Syndication.